P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMICAL ANALYSIS

被引:0
作者
AMBROS, RA
ROSS, JS
KALLAKURY, BVS
MALFETANO, J
KIM, YR
HWANG, J
BREESE, K
FIGGE, J
机构
[1] ALBANY MED COLL,DEPT MICROBIOL,ALBANY,NY 12208
[2] ALBANY MED COLL,DEPT IMMUNOL,ALBANY,NY 12208
[3] ALBANY MED COLL,DEPT MOLEC GENET,ALBANY,NY 12208
[4] ALBANY MED COLL,DEPT MED,ALBANY,NY 12208
[5] ALBANY MED COLL,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,ALBANY,NY 12208
关键词
ENDOMETRIAL CARCINOMA; TUMOR-SUPPRESSOR GENES; P53; GENE; IMAGE ANALYSIS; QUANTITATIVE IMMUNOHISTOCHEMISTRY;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Although detection of p53 protein by immunohistochemical testing was originally thought to indicate p53 gene mutation, recent analyses of human malignancies have shown that high expression of p53 protein may occur without detectable gene mutation. Several explanations have been proposed for this phenomenon, including mutation out of ''hot spot'' regions, overexpression of wild-type protein, sampling error in molecular analyses, and conformational changes of wild-type p53 protein. As discussed, it is unlikely that the first two possibilities contribute significantly to the occurrence of this phenomenon, and the current study examined the possibility that sampling error in molecular analyses might account for a lack of concordance between immunohistochemical and molecular analyses. Such a possibility exists because immunohistochemical studies frequently report high expression when staining is only focal or regional and molecular analyses are based on the polymerase chain reaction, which is highly exponential in nature and may not detect mutation if the target gene segment is not amplified early in the chain reaction. In the current report, p53 protein expression was examined by immunohistochemical testing in 45 cases of endometrioid carcinoma, and all cases showing diffuse positivity were then examined by polymerase chain reaction in combination with single-strand conformational analysis for exons 4 to 9 with the use of a microdissection technique to separate malignant from benign cells. Of the 45 cases, diffuse staining was found in four cases, and only two of the four were found to show evidence of gene mutation. This study concluded that high p53 protein expression can occur without evidence of gene mutation in endometrial carcinoma; because all four cases examined by polymerase chain reaction with single-strand conformational analysis in this study showed diffuse staining by immunohistochemical analysis, it seems unlikely that sampling error in molecular analysis accounts for the lack of concordance. As discussed, it seems distinctly possible that conformational changes of the p53 wild-type protein account for this phenomenon. Further investigation into this possibility might be beneficial.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 25 条
[1]  
AMBROS RA, 1994, CANCER, V73, P1686, DOI 10.1002/1097-0142(19940315)73:6<1686::AID-CNCR2820730622>3.0.CO
[2]  
2-W
[3]   P53 IMMUNOHISTOCHEMISTRY - A WORD OF CAUTION [J].
BATTIFORA, H .
HUMAN PATHOLOGY, 1994, 25 (05) :435-437
[4]   P53-EXPRESSION IN NEOPLASMS OF THE UTERINE CORPUS [J].
BUR, ME ;
PERLMAN, C ;
EDELMANN, L ;
FEY, E ;
ROSE, PG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1992, 98 (01) :81-87
[5]  
ENOMOTO T, 1993, CANCER RES, V53, P1883
[6]  
ESRIG D, 1993, AM J PATHOL, V143, P1389
[7]  
FENAUX P, 1991, BLOOD, V78, P1652
[8]   ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM [J].
GANNON, JV ;
GREAVES, R ;
IGGO, R ;
LANE, DP .
EMBO JOURNAL, 1990, 9 (05) :1595-1602
[9]   MUTATIONAL HOTSPOT IN THE P53 GENE IN HUMAN HEPATOCELLULAR CARCINOMAS [J].
HSU, IC ;
METCALF, RA ;
SUN, T ;
WELSH, JA ;
WANG, NJ ;
HARRIS, CC .
NATURE, 1991, 350 (6317) :427-428
[10]  
HURLIMANN J, 1994, MODERN PATHOL, V7, P423